Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 5/20 | 0.32 |
| ▸ | PIM1 | P11309 | 1/20 | 0.32 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.32 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.32 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.32 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.32 |
| ▸ | SPNS2 | Q8IVW8 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27867261 | 0.95 | CYP19A1 (0.40) | CYP19A1TSHRLMNAHTTSMN1; SMN2 | |
| SCHEMBL585669 | 0.89 | CYP19A1 (0.43) | CYP19A1TSHRLMNAHTTSMN1; SMN2 | |
| SCHEMBL14305754 | 0.85 | CYP19A1 (0.43) | CYP19A1TSHRLMNAHTTSMN1; SMN2 | |
| SCHEMBL27850120 | 0.85 | CYP19A1 (0.45) | CYP19A1TSHRLMNAHTTSMN1; SMN2 | |
| SCHEMBL3868934 | 0.82 | SPNS2 (0.49) | TSHRLMNAMAPTTLR8SPNS2 | |
| SCHEMBL16268174 | 0.82 | CYP19A1 (0.44) | CYP19A1TSHRCYP1A2LMNAHTT | |
| SCHEMBL5691544 | 0.82 | TLR8 (0.42) | CYP19A1TLR8ALDH1A1 | |
| SCHEMBL5691629 | 0.82 | TLR8 (0.42) | CYP19A1TLR8ALDH1A1 | |
| SCHEMBL9645498 | 0.81 | CYP19A1 (0.45) | CYP19A1TSHRLMNAHTTSMN1; SMN2 | |
| SCHEMBL3877612 | 0.79 | CYP1A2 (0.40) | TSHRCYP1A2TLR8PIM1CSNK2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114181377-A | Cyclotriphosphazene-based flame-retardant imidazole curing agent and preparation method and application thereof | 常州百思通复合材料有限公司 | 2022-03-15 | — | — | CN | claimed |
| CN-110016123-B | Heat-resistant flame-retardant epoxy resin latent curing agent | 广东固研电子材料有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-110016123-A | A kind of heat-resisting flame-retardant epoxy resin lalent solidifying agent | 广州市固研电子材料有限公司 | 2019-07-16 | — | — | CN | claimed |
| US-7479527-B2 | Polyepoxide and reaction product of aminoalkylimidazole, polyamine, urea and diepoxide as curing component | FUJI KASEI KOGYO CO., LTD. (JP) | 2009-01-20 | — | — | US | claimed |
| US-20080033116-A1 | One-Component Heat Curable Epoxide Composition | FUJI KASEI KOGYO, CO., LTD. (JP) | 2008-02-07 | — | — | US | claimed |
| EP-0677540-B1 | Process for the preparation of polyurethane foams in the presence of amino alkyl or aminophenyl imidazoles as catalysts, as well as the use of these catalysts for the preparation of polyisocyanate-polyaddition products | BASF AG (DE) | 1999-01-27 | — | — | EP | claimed |
| US-5786402-A | PRODUCING FLEXIBLE FOAM WITH REDUCED ODOR AND REDUCED FOGGING VALUE | BASF AKTIENGESELLSCHAFT (DE) | 1998-07-28 | — | — | US | claimed |
| EP-0677540-A2 | Process for the preparation of polyurethane foams in the presence of amino alkyl or aminophenyl imidazoles as catalysts, as well as the use of these catalysts for the preparation of polyisocyanate-polyaddition products | BASF AKTIENGESELLSCHAFT (DE) | 1995-10-18 | — | — | EP | claimed |
| JP-1146871-A | — | — | None | — | — | JP | disclosed |
| JP-1066172-A | — | — | None | — | — | JP | disclosed |
| EP-4747320-A1 | THERMAL-AND UV-CURABLE (METH) ACRYLATE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260139157-A1 | THERMAL-AND-UV-CURABLE (METH)ACRYLATE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2026-05-21 | — | — | US | disclosed |
| EP-4526365-A1 | ACRYLATE-EPOXY RESIN COMPOSITIONS | Lyondellbasell Composites LLC (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2025015542-A1 | THERMAL-AND UV-CURABLE (METH) ACRYLATE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2025-01-23 | — | — | WO | disclosed |
| JP-H01146871-A | AMINOPROPYLIMIDAZOLE | W R GRACE & CO | 1989-06-08 | — | — | JP | disclosed |
| EP-0188999-B1 | CATIONIC REACTION PRODUCTS FROM 1-AMINOALKYL IMIDAZOLE COMPOUNDS AND EPIHALOGEN HYDRINS | CIBA-GEIGY AG (CH) | 1989-05-31 | — | — | EP | disclosed |
| US-4816589-A | Aminopropylimidazoles | W. R. GRACE & CO.-CONN. (US) | 1989-03-28 | — | — | US | disclosed |
| US-4797455-A | Isocyanates blocked with 1-amino-alkyl imidazoles as epoxy curing agents | W. R. GRACE & CO.-CONN. (US) | 1989-01-10 | — | — | US | disclosed |
| US-4705865-A | Cationic reaction products formed from 1-aminoalkyl-imidazole compounds and epihalohydrins | CIBA-GEIGY CORPORATION (US) | 1987-11-10 | — | — | US | disclosed |
| EP-0188999-A1 | Cationic reaction products from 1-aminoalkyl imidazole compounds and epihalogen hydrins | CIBA-GEIGY AG (CH) | 1986-07-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139157-A1 | THERMAL-AND-UV-CURABLE (METH)ACRYLATE COMPOSITION | MAT1A, MAT2B, MAT2A | CYP19A1 4020/4885TSHR 2841/4885CYP1A2 2509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.